News - archive

    Select here - your selection will appear below

    Your selection

    In The Lancet, Brian Ward and colleagues report two efficacy studies that are, to the best of my knowledge, the first randomised phase 3 trials of a plant-derived quadrivalent influenza vaccine.[1] The vaccine material was generated in Nicotiana benthamiana, a relative of the tobacco plant. The plants were transfected with an attenuated plant viral vector (Agrobacterium tumefaciens) expressing influenza haemagglutinin genes and the vaccine was recovered from the transfected plants in the form of virus-like particles.

    [...] read more

    A man in the U.K. developed sudden and permanent hearing loss in one ear after battling a severe case of COVID-19, according to a new report. His doctors are now warning others to be on the lookout for this rare but serious complication, which has been reported in a handful of COVID-19 patients around the world.

    [...] read more

    The antiviral drug remdesivir does not reduce deaths among COVID-19 patients, as compared with standard care, according to the results of a large, international trial.

    [...] read more

    Even as vaccines are hailed as our best hope against the coronavirus, dozens of scientific groups are working on an alternate defense: monoclonal antibodies. These therapies shot to prominence just this month after President Trump got an infusion of an antibody cocktail made by Regeneron and credited it for his apparent recovery, even calling it a “cure.”

    [...] read more

    The coronavirus treatment President Trump praised as his “cure” was created using a cell line derived from an aborted fetus.

     

    President Trump has lauded the experimental treatment he received for his coronavirus infection, releasing one enthusiastic video on Wednesday and another today.

     

    In Wednesday’s video, Mr. Trump called the cocktail of monoclonal antibodies being developed by the drug maker Regeneron “a cure,” a term he repeated today. He said he would make the treatment free to anyone who needed it, stressing “the seniors” in today’s video.

    [...] read more

    President Donald Trump received an unapproved antibody cocktail as part of his coronavirus treatment, making him one of fewer than 10 people to get the drug outside of a clinical trial, Stat News reported.

    [...] read more

    ORLANDO, Fla. (Ivanhoe Newswire) — The race to find a universal cure for COVID is heating up. Now Vitamin D is making headlines as a possible factor to prevent and treat COVID-19.

    [...] read more

    In early January, the first genome sequence of Sars-CoV-2 — the virus that causes COVID-19 — was released under the moniker "Wuhan-1". This string of 30,000 letters (the A, T, C and Gs of the genetic code) marked day one in the race to understand the genetics of this newly discovered coronavirus. Now, a further 100,000 coronavirus genomes sampled from COVID-19 patients in over 100 countries have joined Wuhan-1. Geneticists around the world are mining the data for answers. Where did Sars-CoV-2 come from? When did it start infecting humans? How is the virus mutating — and does it matter? Sars-CoV-2 genomics, much like the virus itself, went big and went global.

    [...] read more

    Up to 206 Million People Reached and Over 5.4 Million Trained in Cardiopulmonary Resuscitation Worldwide: The 2019 International Liaison Committee on Resuscitation World Restart a Heart Initiative

    [...] read more

    The research does not prove that infected children are contagious, but it should influence the debate about reopening schools, some experts said. It has been a comforting refrain in the national conversation about reopening schools: Young children are mostly spared by the coronavirus and don’t seem to spread it to others, at least not very often.

     

    But on Thursday, a study introduced an unwelcome wrinkle into this smooth narrative.

    [...] read more